| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Telix Pharmaceuticals Limited (AU: TLX)
TLX Technical Analysis
5
| As on 17th Dec 2025 TLX STOCK Price closed @ 11.73 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 23.19 & Strong Sell for SHORT-TERM with Stoploss of 25.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TLXSTOCK Price
| Open | 12.62 | Change | Price | % |
| High | 12.73 | 1 Day | -0.83 | -6.61 |
| Low | 11.54 | 1 Week | -2.86 | -19.60 |
| Close | 11.73 | 1 Month | -3.83 | -24.61 |
| Volume | 6313208 | 1 Year | -12.05 | -50.67 |
| 52 Week High 31.14 | 52 Week Low 11.73 | ||||
AU Australia Most Active Stocks
| OVT | 0.00 | % |
| NTU | 0.03 | % |
| LKE | 0.10 | 11.11% |
| OEL | 0.00 | % |
| LTR | 1.51 | 11.03% |
| EQR | 0.07 | 16.67% |
| ARU | 0.22 | 4.76% |
| AQI | 0.10 | 66.67% |
| CAN | 0.01 | 0.00% |
| PLS | 4.06 | 4.64% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| TLX Daily Charts |
TLX Intraday Charts |
Whats New @ Bazaartrend |
TLX Free Analysis |
|
|
TLX Important Levels Intraday
| RESISTANCE | 14.02 |
| RESISTANCE | 13.29 |
| RESISTANCE | 12.83 |
| RESISTANCE | 12.38 |
| SUPPORT | 11.08 |
| SUPPORT | 10.63 |
| SUPPORT | 10.17 |
| SUPPORT | 9.44 |
TLX Forecast December 2025
| 4th UP Forecast | 23.79 |
| 3rd UP Forecast | 19.92 |
| 2nd UP Forecast | 17.53 |
| 1st UP Forecast | 15.14 |
| 1st DOWN Forecast | 8.32 |
| 2nd DOWN Forecast | 5.93 |
| 3rd DOWN Forecast | 3.54 |
| 4th DOWN Forecast | -0.33 |
TLX Weekly Forecast
| 4th UP Forecast | 14.29 |
| 3rd UP Forecast | 13.47 |
| 2nd UP Forecast | 12.96 |
| 1st UP Forecast | 12.45 |
| 1st DOWN Forecast | 11.01 |
| 2nd DOWN Forecast | 10.50 |
| 3rd DOWN Forecast | 9.99 |
| 4th DOWN Forecast | 9.17 |
TLX Forecast2025
| 4th UP Forecast | 51.1 |
| 3rd UP Forecast | 38.47 |
| 2nd UP Forecast | 30.67 |
| 1st UP Forecast | 22.86 |
| 1st DOWN Forecast | 0.6 |
| 2nd DOWN Forecast | -7.21 |
| 3rd DOWN Forecast | -15.01 |
| 4th DOWN Forecast | -27.64 |
Telix Pharmaceuticals Limited ( AU Australia Symbol : TLX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TLX Business Profile
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States. The company focuses on developing diagnostic and therapeutic products using molecularly targeted radiation (MTR). Its lead products include TLX250, which is in Phase II clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX250-CDx that is in Phase III clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX591, which is in pre-Phase 3 development for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX591-CDx that is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; and TLX101, which is in Phase I/II clinical trial for the treatment of glioblastoma (brain cancer). The company has a strategic collaboration with RefleXion Medical for the treatment of high-risk cancers; a strategic license and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited for developing a portfolio of MTR products; and scientific and clinical research collaboration with Mauna Kea Technologies. In addition, it has a collaboration with Kanazawa University to commence a Phase I trial of prostate cancer imaging product TLX591-CDxin Japan; and strategic collaboration agreement with Lightpoint Medical, Ltd. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Address: 55 Flemington Road, North Melbourne, VIC, Australia, 3051
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service